Category: Include on Menu

Shares of BioMarin Pharmaceutical (NASDAQ:BMRN) and Ascendis Pharma (NASDAQ:ASND) fell roughly 6% after rival BridgeBio Pharma (NASDAQ:BBIO) reported encouraging Phase 3 results for its experimental achondroplasia therapy. BridgeBio said its oral drug infigratinib achieved the primary endpoint in the late-stage PROPEL 3 trial, delivering superior annualized height velocity compared with placebo. The company cited a…

BridgeBio Pharma (NASDAQ:BBIO) shares climbed about 9% on Thursday after the biotech group unveiled positive Phase 3 topline results for its oral drug infigratinib in achondroplasia, marking what it said were the first statistically significant gains in body proportionality seen in the condition. The late-stage PROPEL 3 study met its primary endpoint, showing that patients…

Iron Mountain Incorporated (NYSE:IRM) delivered fourth-quarter results ahead of market expectations, capping a year of record-setting performance and lifting its shares more than 2% in premarket trading on Thursday. The information management and data services group reported adjusted earnings per share of $0.61, edging past analyst estimates of $0.60. Revenue rose 16.6% year over year…

Howmet Aerospace (NYSE:HWM) issued a first-quarter outlook that topped Wall Street expectations, sending its shares more than 2% higher in premarket trading on Thursday, as the jet engine components supplier pointed to improving profitability and cash flow in 2026. The upbeat forecast comes as production of popular single-aisle aircraft by Boeing and Airbus continues to…

Exelon Corporation (NASDAQ:EXC) reported fourth-quarter adjusted earnings ahead of Wall Street estimates on Thursday, even as revenue trailed expectations. Shares rose 0.38% in pre-market trading following the release. The utility group posted adjusted earnings of $0.59 per share for the quarter, beating analyst forecasts of $0.57. Revenue totaled $5.41 billion, missing the $5.51 billion consensus…

Kimco Realty (NYSE:KIM) delivered fourth-quarter results ahead of Wall Street expectations, helped by robust leasing momentum and record-high occupancy across its shopping center portfolio. The retail-focused REIT posted earnings per share of $0.21, exceeding analyst estimates by $0.03. Quarterly revenue totaled $542.46 million, above the consensus forecast of $537.32 million. Shares gained 1.05% in after-hours…

Entergy Corporation (NYSE:ETR) reported fourth-quarter 2025 earnings below Wall Street expectations, sending shares down 2.45% in premarket trading Thursday. The utility posted earnings of $0.51 per share on both a reported and adjusted basis, missing analyst estimates of $0.54 per share. For full-year 2025, Entergy generated earnings of $3.91 per share, placing results in the…

Viking Therapeutics Inc. (NASDAQ:VKTX) surged 11.63% after unveiling plans to advance its experimental oral obesity treatment, VK2735, into Phase 3 trials in the third quarter of this year. The biotech firm said late-stage study data showed that once-daily dosing of the oral VK2735 tablet led to average weight loss of up to 12.2% after 13…

Granite Construction Incorporated (NYSE:GVA) delivered fourth-quarter results ahead of Wall Street expectations on Thursday, supported by robust revenue growth and expanding margins across its operations. Shares were little changed in premarket trading, slipping 0.13% following the release. The infrastructure builder reported adjusted earnings per share of $1.40, comfortably above the $1.13 consensus estimate. Revenue climbed…